SECsense Logo

Mesoblast Limited Financial Report: Key Securities Filings & Announcements (Jan 2025)

$MESO
Form 6-K
Filed on: 2025-01-16
Source
Mesoblast Limited Financial Report: Key Securities Filings & Announcements (Jan 2025)

Here are the key insights extracted from the provided section of the financial report (Form 6-K) for Mesoblast Limited:

General Information:

  • Filing Date: January 15, 2025
  • Company Name: Mesoblast Limited
  • Jurisdiction: Australia
  • Commission File Number: 001-37626
  • CEO: Silviu Itescu
  • Company Secretary: Niva Sivakumar
  • Principal Executive Office Address: Level 38, 55 Collins Street, Melbourne 3000, Australia

Key Filings and Announcements:

  1. January 14, 2025:
  • Filed a press release with the Australian Securities Exchange (Exhibit 99.1).
  • Proposed issue of securities (Appendix 3B attached as Exhibit 99.2).
  1. January 10, 2025:
  • Filed a new issue announcement and application for quotation of securities (Appendix 2A attached as Exhibits 99.3 and 99.4).
  1. January 6, 2025:
  • Filed another proposed issue of securities (Appendix 3B attached as Exhibit 99.5).

Filing Purpose:

  • The report is submitted as part of compliance with the Securities Exchange Act of 1934, specifically under Rule 13a-16 or 15d-16 for foreign private issuers.

Additional Notes:

  • The report signals ongoing capital market activities, including securities issues which may reflect the company’s strategic initiatives for funding or expansion.
  • The filings are significant for investors and analysts monitoring the company's financial health and market activities.

This report serves as a communication of important corporate actions and regulatory compliance for Mesoblast Limited, primarily focused on securities and financial announcements.